scorecardresearch
Add as a preferred source on Google
Saturday, November 15, 2025
TopicAIDS

Topic: AIDS

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

Climate crisis could increase HIV infections and AIDS related deaths, UN warns

At the COP29 in Baku, UNAIDS and UNDP presented a report that highlights how climate change could exacerbate existing vulnerabilities to HIV.

More people dying from lack of access to antibiotics. It is leading to rise in drug resistance

By 2050, the total number of deaths associated with drug resistance are expected to reach a staggering 169 million.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

New hope for HIV cure as third patient shows signs of remission after stem cell transplant

Senior physician Björn-Erik Ole Jensen says allogeneic hematopoietic stem cell transplant is a strong answer to curing HIV-1

Manforce AIDS campaign is confused about what to market—awareness or social responsibility

In 2020, Manforce campaign asked Indians to use condoms without thinking about the brand, a clever way to build goodwill. This time it has fallen short.

New drugs mean AIDS is no longer life-limiting. But here’s why elderly will be left out

The threats and implications of HIV infection for older people are as serious as they are for younger age groups.

World AIDS Day: 57% Indians don’t use contraception, Ahmedabad ranks lowest, survey finds

The survey findings come the same day UNAIDS warns of possible '7.7 million more AIDS-related deaths' in next 10 years.

Moderna backtracks to now open Covid vaccine trial to HIV-positive people

The move came after advocacy groups pushed Moderna, noting that people with health conditions are among the most at-risk from the novel coronavirus.

On Camera

Why Tejashwi Yadav failed—Bihar changed, RJD didn’t

RJD, once a prominent representative of Mandal politics, now finds itself in a political era where welfare, good governance, and new aspirations are overshadowing old caste equations.

As govt starts rolling back Quality Control Orders, a look at adverse impact they had, mainly on MSMEs

Between 2016 and 2025, around 700 QCOs were issued by the government. Now, it has withdrawn 69 of them.

Drone manufacturer ideaForge wins orders worth over Rs 100 crore from Army

ideaForge has formed a joint venture to manufacture and market UAVs in the US. Its Q6 UAV is now included in NATO and allied procurement systems.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.